GABAA - Benzodiazepine-Chloride Receptor-Targeted Therapy forTinnitus Control: Preliminary Report
Our goal was to attempt to establish neurophannacological tinnitus control (i.e., relief
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Our goal was to attempt to establish neurophannacological tinnitus control (i.e., relief
N umerous studies have demonstrated that targeting immunogens to Fc receptors (FcR
checkpoint inhibitors. Furthermore, we found high-risk TNBC patients had enhanced sensitivity to nuclear receptor-targeting agents [Figure 1]. Conclusion: A neutrophil-related gene signature could predict decreased…
Purpose: Cy754 was combined with Rituximab to prepare a new receptor-targeted tracer for Sentinel Lymph Node (SLN). The appropriate combination ratio of the tracer was identified, the biological property ... tracer was…
Cancer is an ever-increasing menace that needs to be curbed soon
Worldwide, there are more than 370 million people who are chronically infected
A key goal of our research is the targeted delivery of functional
these characteristics have been applied towards novel enhanced combination therapeutics with VPA and specific receptor-targeted cytotoxic peptide-drug conjugates
idiopathic tinnitus of the severe disabling type and who completed a treatment protocol called receptor-targeted therapy directed to the GABAA receptor. The drugs used were gabapentin and clonazepam. Using
novel ligands and allosteric modulators. Advances in pharmacology have fostered the development of receptor-targeted therapies that exhibit remarkable efficacy and selectivity, resulting in improved patient outcomes…
Objective: To provide to the tinnitus professional a rationale for establishing accuracy
We present a tinnitus-targeted therapy (TTT), a combined treatment of medication
traditional therapies displayed very limited benefits, with a poor five-year survival rate. The receptor-targeting therapy is becoming a new hot topic. Our previous studies demonstrated the receptor-targeting
drugs which could promote fewer side effects. Thrombosis can be manged through advancements in receptor-targeted therapies, combined with novel ligand discoveries. This would ensure safer and more effective treatment
clinical trials and ultimately to the clinic. With continued innovation and investment in opioid receptor-targeted drug
severely toxic side effects, and result in multidrug resistance (MDR) of cancer cells. So, receptor-targeted therapy is catching more attention of scientists from both academic and industry and recently
receptor, which are cellular receptors highly expressed in many types of human cancers. These receptor-targeted IONPs are engineered to carry single or multiple drugs for targeted delivery, multi-modality
have developed a multifunctional theranostic magnetic iron oxide nanoparticle (IONP) platform that utilizes receptor-targeted IONPs to carry single or multiple therapeutic agents for drug delivery and optical and…
Previously, folic acid receptor-targeted Dextran-Taxol-Folic acid (Dex-TXL-FA) has shown the in vitro superior and selective antitumor activity against human oral cancer cell line (KB) compared
rationale for treatment directed to a presumed ischemia of brain based on a receptor-targeted therapy targeted to the GABA-A receptor, resulting in significant tinnitus relief. Questions that have
For authors and organisers
Find the right journal for your paper and submit your manuscript.